Driving the future of digital clinical trials
WALTHAM, MA — Mar. 10, 2022 — OpenClinica, the leader in eclinical solutions and clinical trial support (electronic data capture (EDC), ePRO/eCOA, EHR eSource, randomization, and reporting), today announced the unveiling of its refreshed website, openclinica.com, and its investment in overall growth in 2022 and beyond.
Building on top of its foundational technologies that have served biotechs, large pharmaceutical companies, academic research organizations (AROs), contract research organizations (CROs), and major government bodies for 16+ years, OpenClinica is also proud to announce its investment in and expansion of its solutions and service offerings.
From work to support critically important COVID-19 research, including one of the largest randomized clinical trials for COVID-19 treatments, to enabling decentralized clinical trials, real-world data collection, EHR integrations, and next generation technologies, OpenClinica is on the forefront of the most innovative research to date, bringing breakthrough solutions to sites and sponsors.
“We are driving the future of digital clinical trials. Today’s clinical researchers expect more. They are increasing their use of technology to collect better data, faster and with more choices than ever before. We are happy to provide a robust, best-of-breed offering that expands upon the typical electronic data capture (EDC) solution,” said Cal Collins, CEO at OpenClinica.
The announcement comes on the heels of OpenClinica’s newest product, OpenClinica Unite™, an integrated EHR eSource site solution that enables clinical trial site staff, such as clinicians and clinical research coordinators, to pull electronic health record (EHR) data into their study database / electronic data capture (EDC) system 15 times faster than traditional methods.
In addition to this extended solution offering, the company doubled its staff over the past year to align with its uptick in business partnerships. An increase of professional service and solution consultants, among other roles, will build on OpenClinica’s history of frictionless customer experiences. Whether clients need a little help or complete extensions of their team, OpenClinica will always support these needs.
To learn more about OpenClinica and stay up to date on the latest and greatest thoughts, opinions, and offerings, please visit www.openclinica.com.
OpenClinica is transforming healthcare through innovative cloud technology that simplifies running clinical trials. Proven in over 10,000 studies worldwide, the OpenClinica platform is trusted by leading biopharmaceutical companies, contract research organizations, academic institutions, and government agencies. OpenClinica is used across a wide spectrum of clinical research, including drug, device, and diagnostic trials, global health studies involving 200,000 patients, adaptive platform trials, and clinical trials for some of the first gene therapies to be approved for market. Hundreds of small, midsize, and large research organizations leverage OpenClinica to capture better clinical data faster and to do so in a way that meets the highest standards for security and regulatory compliance (21 CFR Part 11, Annex 11, GDPR, HIPAA).
OpenClinica, LLC is headquartered in Waltham, MA. For more information on OpenClinica’s solutions for electronic data capture (EDC), eSource, ePRO, randomization, and analytics and reporting – visit www.openclinica.com.
For media inquiries, please contact:
Director of Marketing